Skip to content
Screener

Revvity RVTY Diagnostics — Restructuring and Other Costs (Income)

Other segment segments

Life Sciences
$3.23M+27.7%

Similar metrics at other companies

MSC Industrial Direct Co. logo
MSMReportable Segment — Restructuring and other costs
$0-100%
Matrix Service Company logo
MTRXCorporate Segment — Restructuring costs and other
$1.99M
Twist Bioscience Corporation logo
TWSTReportable Segment — Restructuring and other costs
$0
Herbalife logo
HLFOthers — Restructuring Costs
$0
Hooker Furnishings Corporation logo
HOFTAll Other — Restructuring Costs
$5K-87.5%
Matrix Service Company logo
MTRXProcess and Industrial Facilities — Restructuring costs and other
$94K

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCosts.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemThree Months Ended / April 5,2026Three Months Ended / March 30,2025
Life Sciences$3,229$2,528
Diagnostics7,554135
Corporate(108)576
$10,675$3,239

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's diagnostics — restructuring and other costs (income)?
Revvity (RVTY) reported diagnostics — restructuring and other costs (income) of $7.55M in Q1 2026.
How has Revvity's diagnostics — restructuring and other costs (income) changed year-over-year?
Revvity's diagnostics — restructuring and other costs (income) increased by 5495.6% year-over-year, from $135K to $7.55M.
What does diagnostics — restructuring and other costs (income) mean?
Captures non-recurring expenses or income related to organizational changes, such as facility consolidations, workforce reductions, or strategic realignments within the diagnostics segment. These costs are typically excluded from core operating performance to show underlying business trends.

Ask your AI about Revvity's diagnostics — restructuring and other costs (income).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude